Show items per page
Elements: 34
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010
add to browser selection
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study Rotger, Margalida; Bayard, Cornelia; Taffe, Patrick; Martinez, Raquel; ... Tarr, P. E. 2009
add to browser selection
Antiretroviral treatment during pregnancy Keiser, Olivia; Gayet-Ageron, Angèle; Rudin, Christoph; Brinkhof, M. W.; ... de Tejada, B. M. 2008
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Wunder, D. M.; Bersinger, N. A.; Fux, C. A.; Mueller, N. J.; ... Furrer, Hansjakob 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Late presentation of HIV-infected individuals Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob 2007
add to browser selection
Ferritin levels during structured treatment interruption of highly active antiretroviral therapy Boom, J.; Kosters, E.; Duncombe, C.; Kerr, S.; ... Ananworanich, J. 2007
add to browser selection
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions Joos, Beda; Trkola, Alexandra; Fischer, Marek; Kuster, Herbert; ... Gunthard, Huldrych 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef Fischer, Marek; Joos, Beda; Hirschel, Bernard; Bleiber, Gabriela; ... Gunthard, Huldrych 2004
add to browser selection
Successful treatment of disseminated tuberculosis and acquired immunodeficiency syndrome in an 81-y-old woman Laszlo, Andre; Gianelli, Sandra; Laurencet, France; Krause, Karl-Heinz; Janssens, Jean-Paul 2003
add to browser selection
Antiretroviral treatment and research in resource-poor countries Hirschel, Bernard 2003
add to browser selection
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts Fischer, Marek; Wong, J. K.; Russenberger, Doris; Joos, Beda; ... Gunthard, Huldrych 2002
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Greub, Gilbert; Ledergerber, Bruno; Battegay, M.; Grob, P.; ... Telenti, A. 2000
<< previous | 1 | 2 |